who should not take glp-1 Why I'm Choosing to GLP-1s, Even Though Everyone Expects Me To Who Should Not Take Ozempic?
Description
JCI Insight 2020
ADA guidance also notes benefits of GLP-1 RAs in diabetes patients who also have cardiovascular disease, chronic kidney disease, or obesity-linked complications
Products that do not disclose testing practices or provide clear contact information should be approached with caution, particularly when marketed for metabolic or weight-related outcomes
Its dual GIP/GLP-1 mechanism targets appetite suppression and insulin response, but does not add the energy-expenditure dimension that retatrutide's glucagon arm provides
(2016) Novel extrapancreatic effects of incretin
